Abstract
The stress-induced release of ACTH is believed to involve the activation of several humoral and neural pathways, including corticotropin-releasing factor (CRF)1–4, catecholamines5–12 and vasopressin13–17. The essential role of CRF was supported by our observation that immunoneutralization of this releasing factor significantly lowers plasma ACTH levels of ether-stressed rats2. However, the presence of a small but measurable residual ACTH secretion suggested the possible involvement of factors other than CRF in the stress response2. We report here that pretreatment with a vasopressin antagonist decreases the plasma ACTH levels of ether-stressed rats in later (10–20 min), but not earlier (0–10 min), phases of ether stress. The ganglionic blocker chlorisondamine, inhibits ACTH release during both phases of the response to ether by 40–60% when used alone, and by 100% when administered with anti-CRF antibody. These results support a role of CRF, catecholamines and vasopressin in mediating ACTH release by ether stress.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vale, W., Spiess, J., Rivier, C. & Rivier, J. Science 213, 1394–1397 (1981).
Rivier, C., Rivier, J. & Vale, W. Science 218, 377–379 (1982).
Ruhmann-Wennhold, A. & Nelson, D. H. in Endocrinology (ed. Degroot, L. J.) 133–140 (Grune & Stratton, New York, 1979).
Yasuda, N., Greer, M. A. & Aizawa, T. Endocrine Rev. 3, 123–140 (1982).
Holland, F. J., Richards, G. E., Kaplan, S. L., Ganong, W. F. & Grumbach, M. M. Endocrinology 102, 1452–1457 (1978).
Lancranjan, I., Ohnhaus, E. & Girard, J. J. clin. Endocr. Metab. 49, 227–230 (1979).
Tilders, F. J. H., Berkenbosch, F. & Smelik, P. G. Endocrinology 110, 114–120 (1982).
Van Loon, G. R., Scapagnini, U., Moberg, B. & Ganong, W. F. Endocrinology 89, 1464–1469 (1971).
Jones, M. T., Hillhouse, E. & Burden, J., Ann. N.Y. Acad. Sci. 297, 536–538 (1977).
Jones, M. T., Hillhouse, S. & Burden, J. in Frontiers in Neuroendocrinology Vol. 4 (eds Ganong, W. F. & Martini, L.) 195 (Raven, New York, 1976).
Buckingham, J. C. & Hodges, P. R. J. Physiol., Lond. 272, 469 (1977).
Hillhouse, E. W., Burden, J. & Jones, M. T. Neuroendocrinology 17, 1–5 (1975).
Nichols, B. L. Jr Yale J. Biol. Med. 33, 415–425 (1961).
Gillies, G. & Lowry, P. J. J. Endocr. 84, 65–73 (1980).
Conte-Devolx, B. et al. Endocrinology 110, 2097–2100 (1982).
Buckingham, J. C. Pharmac. Rev. 31, 253–275 (1980).
Gillies, G. & Lowry, P. Nature 278, 463–464 (1979).
Vale, W. et al. Meth. Enzym. (in the press).
Rivier, J., Spiess, J. & Vale, W. Proc. natn. Acad. Sci. U.S.A. (in the press).
Gillies, G. E., Linton, E. A. & Lowry, D. J. Nature 299, 355–357 (1982).
Giguere, V., Cote, J. & Labrie, F. Endocrinology 109, 757–762 (1981).
Giguere, V., Cote, J. & Labrie, F. Endocrinology 110, 1225–1230 (1982).
Beny, J. L. & Baertschi, A. J. Endocrinology 109, 813–817 (1981).
Vale, W. & Rivier, C. Fedn Proc. 36, 2094–2099 (1977).
Vale, W. et al. Endocrinology (in the press).
Raymond, V. et al. Molec. cell. Endocr. 22, 295–298 (1981).
Berkenbosch, F., Vermes, I., Binnekade, R. & Tilders, F. J. H. Life Sci. 29, 2249–2256 (1981).
Silves, G. & Lowry, P. J. Nature 218, 463–464 (1979).
Turkelson, C. M. et al. Peptides 1, 111–113 (1982).
Beny, J. L. & Baertschi, A. J. Experientia 38, 1078–1079 (1982).
Rivier, C. & Vale, W. Endocrinology (in the press).
Linton, E. A. & Gillies, G. E. 64th A. Meet. Endocrine Society, San Francisco (1982).
Kvetnansky, R. et al. Endocrinology 103, 1868–1874 (1978).
McCarty, R., Gilad, G. M., Weise, V. K. & Kopin, I. J. Life Sci. 25, 747–754 (1979).
Kopin, I. J., McCarty, R., Torda, T. & Yamaguchi, I. in Catecholamines and Stress: Recent Advances (eds Usdin, E., Kvetriansky, R. & Kopin, I. J.) 197–204 (Elsevier, Amsterdam, 1980).
McCarty, R. & Kopin, I. J. Behav. Neural Biol. 27, 249–265 (1979).
Hedge, G. A., Van Ree, J. M. & Versteeg, D. H. G. Neuroscience 21, 236–246 (1976).
Kvetnansky, R., Kopin, I. J. & Saavedra, J. M. Brain Res. 155, 387–390 (1978).
Saavedra, J. M., Kvetnansky, R. & Kopin, I. J. Brain Res. 160, 271–280 (1979).
Saavedra, J. M. Neuroendocrinology 35, 396–401 (1982).
Brown, M. R. et al. Endocrinology 111, 928–931 (1982).
Brown, M. et al. Endocrinology 110, 225 (1982).
Carlson, D. E., Dornhorst, A., Seif, S. M., Robinson, A. G. & Gann, D. S. Endocrinology 110, 680–682 (1982).
Aizawa, T., Yasuda, N., Greer, M. A. & Sawyer, W. H. Endocrinology 110, 98–104 (1982).
Bantzowski, K., Manning, M., Haldar, J. & Sawyer, W. H. J. med. Chem. 21, 850–853 (1978).
Mormede, P. Nature 302, 345–346 (1983).
Palkovits, M., Ann. N.Y. Acad. Sci. 237, 455–475 (1977).
Forsling, M. L. & Ullman, E. J. Physiol., Lond. 241, 35P (1974).
Saffran, M. & Schally, A. V. Can. J. Biochem. Physiol. 33, 308–315 (1955).
Weiner, R. I. & Ganong, W. F. Physiol. Rev. 58, 905–976 (1978).
Ganong, W. F. Fedn Proc. 39, 2923–2930 (1980).
Taylor, P. in The Pharmacological Basis of Therapeutics (eds Goodman Gilman, A., Goodman, L. S. & Gilman, A.) 211–219 (Macmillan, New York, 1980).
Fischer, D. A. & Brown, M. Endocrinology 107, 714–718 (1980).
Rivier, C., Brownstein, M., Spiess, J., Rivier, J. & Vale, W. Endocrinology 110, 272–278 (1982).
Rivier, J., Spiess, J., Rivier, C., Lederis, K. & Vale, W. 17th Eur. Peptide Symp. Prague (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rivier, C., Vale, W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305, 325–327 (1983). https://doi.org/10.1038/305325a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/305325a0
This article is cited by
-
Neurocognitive effects of stress: a metaparadigm perspective
Molecular Psychiatry (2023)
-
New insights on diagnosis and treatment of AVP deficiency
Reviews in Endocrine and Metabolic Disorders (2023)
-
Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
Journal of Neuroinflammation (2022)
-
Functional diversity of corticotropin-releasing hormone
Nature Reviews Endocrinology (2022)
-
Genomic polymorphisms at the crhr2 locus improve feed conversion efficiency through alleviation of hypothalamus-pituitary-interrenal axis activity in gibel carp (Carassius gibelio)
Science China Life Sciences (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.